Xenon Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. EROC
4. IQMX
5. SEER
6. FRBT
7. MSTR
8. SNDK
9. NVDA
10. SPGI

Go back to Xenon Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals (XENE) Tops Q2 EPS by 6c

August 3, 2016 5:26 PM EDT

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of ($0.42), $0.06 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $400 thousand versus the consensus estimate of $2.25 million.

Dr. Simon Pimstone, Xenon's President and Chief Executive Officer, said, Our proprietary programs continue to advance as we make strong progress towards our... More